This Thanksgiving promises to be unlike any other: a global pandemic, newly approved weed laws, and oh, it’s an election year? There’s clearly a lot going on this turkey season, so we thought we’d sit down with a plate and take a look at where we find ourselves on the national day of giving thanks.
October was a month filled with worldwide cannabis legislation and other significant activity. With several positives and a few substantial setbacks along the way, the global cannabis picture began to clarify by the end of October, for better or worse.
Flower costs continue to fluctuate as supply issues run into overwhelming demands and remain higher than average for a legalized state. Possibly due to this, edibles are gaining in popularity among cannabis consumers living in those states.
The bud and breakfast concept has slowly but surely gained traction across several United States markets. The 420 friendly lodging space requires significant growth and maturation. However, despite its modest positioning today, several in the cannabis space believe the sector could soon boom.
More consumers have become curious about the possibilities of other cannabinoids beyond delta-9 THC and CBD. The new up-and-comer seems to be delta-8 THC. Its widespread availability and lack of delta-9 molecules have led many to wonder: will consuming delta-8 affect the outcome of a drug test?
There are a variety of ways to ingest CBD, and many consumers prefer to vape CBD because it’s fast-acting, convenient, and smokeless. However, unless you buy it from a dispensary you trust in a legal state, there is literally no oversight on the safety and efficacy of most CBD vapes out there.
Cannabis enthusiasts have been arguing for decades about who is responsible for the discovery of THC. Click here to learn more about the history of this euphoric compound and how it actually came to be identified.